Skip to Content
A Dose of Economics podcast graphic titled 'Most Favored Nation pricing: what it means for policy, patients and pharma,' featuring Neil Grubert, Independent Global Market Access Consultant, and Amanda Cole, Director at the Office of Health Economics.

Most Favored Nation pricing: what it means for policy, patients and pharma

Back to all articles

President Trump says the rest of the world is free-riding on American pharmaceutical prices. But what will substantial policy change mean for patients in the US and around the world?

Most Favored Nation pricing: what it means for policy, patients and pharma

 

View More